PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Global Regulatory Science and Policy, Sanofi R&D, Chilly-Mazarin, France.\', \'Global Quality External Liaisons, GB Aventis Pharma Ltd, Reading, United Kingdom.\', \'Global Quality External Liaisons, Sanofi Winthrop Industrie, Gentilly, France.\', \'Global Regulatory Science and Policy, Sanofi KK, Tokyo, Japan.\', \'Sanofi Pasteur Global Quality, Inspection Readiness & Site Support, Lyon-Carteret, France.\', \'Global Regulatory Science and Policy, Sanofi R&D, Chilly-Mazarin, France. Electronic address: thomas.kuhler@sanofi.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0149-2918(21)00398-210.1016/j.clinthera.2021.10.003
?:doi
?:hasPublicationType
?:journal
  • Clinical therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34740466
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.151
?:rankingScore_hIndex
  • 120
?:title
  • The Utility of Remote Inspections During the COVID-19 Health Emergency and in the Postpandemic Setting.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34740466>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34740466>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all